Pathogenesis of lung disease in cystic fibrosis

Respiration

Volumn 67, Issue 1, 2000, Pages 3-8

  Dinwiddie, Robert ^a  

^a GREAT ORMOND STREET HOSPITAL   (United Kingdom)

Author keywords

Bronchiectasis; Cystic fibrosis; Inflammation; Interleukin 8; Pseudomonas aeruginosa

Indexed keywords

CHLORIDE; INTERLEUKIN 8; PROTEINASE INHIBITOR; TRANSMEMBRANE CONDUCTANCE REGULATOR;

ADOLESCENT; ADULT; BRONCHIECTASIS; CHILD; CYSTIC FIBROSIS; FLUID BALANCE; HAEMOPHILUS INFLUENZAE; HUMAN; INFLAMMATION; LUNG DISEASE; LUNG INFECTION; LUNG INJURY; MUCUS; NEUTROPHIL; PATHOGENESIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; REVIEW; SODIUM BALANCE; STAPHYLOCOCCUS AUREUS; VISCOSITY;

EID: 0034005178     PISSN: 00257931     EISSN: None     Source Type: Journal    
DOI: 10.1159/000029453     Document Type: Review

References (32)

1. Riordan JR, Kommens JM, Kerem B, Alon N, Rozmahel R, Grzelezak Z, Zielenski J, Lok S, Plavsic N, Chou JL, et al: Identification of the cystic fibrosis gene: Cloning and characterization of complementary DNA. Science 1989; 245:1066-1073.
2. Boucher RC: ASL in normal and CF subjects is isotonic: Evidence for the isotonic volume absorption/mucus clearance hypothesis for the pathogencsis of early CF lung disease. Pediatr Pulmonol Suppl 1998;17:132.
3. Accurso FJ, Sokol RJ, Hammond KB, Abman SH: Early respiratory course in infants with cystic fibrosis: Relevance to newborn screening. Pediatr Pulmonol Suppl 1991;7:42-45.
4. Wilmott RW, Kassab JT, Kilian PL, Benjamin WR, Douglas SD, Wood RE: Increased levels of interleukin-1 in bronchoalveolar washings from children with bacterial pulmonary infections. Am Rev Respir Dis 1990;142:365-368.
5. Konstan MW, Hilliard KA, Norvel TM, Berger M: Bronchoalveolar lavage findings in cystic fibrosis patients with stable, clinically mild disease suggest ongoing infection and inflammation. Am J Respir Crit Care Mcd 1994;150: 448-454.
6. Birrer P, McElvaney NG, Rudeberg A, Sommer CW, Liechti-Gallati S, Kraemer R, Hubbard R, Crystal RG: Protease antiprotease inbalance in the lungs of children with cystic fibrosis. Am J Respir Crit Care Med 1994;150: 207-213.
7. Armstrong DS, Grimwood K, Carzino R, Carlin JB, Olinsky A, Phelan PD: Lower respiratory tract infection and inflammation in infants with newly diagnosed cystic fibrosis. BMJ 1995;310:1571-1572.
8. Khan TZ, Wagener JS, Bost T, Martinez J, Accurso FJ, Riches DW: Early pulmonary inflammation in infants with cystic fibrosis. Am J Respir Crit Care Med 1995;151:1075-1082.
9. DiMango E, Ratner AJ, Bryan R, Tabibi S, Prince A: Activation of NF-kappaB by adherent Pseudomonas aeruginosa in normal and cystic fibrosis respiratory epithelial cells. J Clin Invest 1998;101:2598-2605.
10. Goldstein W, Doring G: Lysosomal enzymes from polymorphonuclear leukocytes and proteinase inhibitors in patients with cystic fibrosis. Am Rev Respir Dis 1986;134:49-56.
11. Konstan MW, Walenga RW, Hilliard KS, Hilliard JB: Leukotriene B4 markedly elevated in the epithelial lining fluid of patients with cystic fibrosis. Am Rev Respir Dis 1993;148:896-901.
12. Greally P, Hussein MJ, Cook AJ, Sampson AP, Piper PJ, Price JF: Sputum tumour necrosis factor-alpha and leukotriene concentrations in cystic fibrosis. Arch Dis Child 1993;68:389-392.
13. Armstrong DS, Grimwood K, Carlin JB, Carzino R, Gutierrez JP, Hull J, Olinsky A, Phelan EM, Robertson CF, Phelan PD: Lower airway inflammation in infants and young children with cystic fibrosis. Am J Respir Crit Care Med 1997;156:1197-1204.
14. Cantin A: Cystic fibrosis lung inflammation: Early, sustained, and severe. Am J Respir Crit Care Med 1995;151:939-941.
15. Bonfield TL, Konstan WM, Burfeind P, Panuska JR, Hilliard JB, Berger M: Normal bronchial epithelial cells constitutively produce the anti-inflammatory cytokine interleukin-10, which is downregulated in cystic fibrosis. Am J Respir Cell Mol Biol 1995;13:257-261.
16. McElvaney NG, Hubbard RC, Birrer P, Chernick MS, Caplan DB, Frank MM, Crystal RG: Aerosol alpha 1-antitrypsin treatment for cystic fibrosis. Lancet 1991;337:392-394.
17. Carver AS, Dalrymple MA, Wright G, Cotton DS, Reeves DB, Gibson YH, Keenan IL, Barrass JD, Scott AR, Colman A, et al: Transgenic livestock as bioreactors: Stable expression of human alpha-1-antitrypsin by a flock of sheep. Biotechnology (NY) 1993;11:1263-1270.
18. Bingle L, Tetley TD: Secretory leukoprotease inhibitor: Partnering alpha 1-proteinase inhibitor to combat pulmonary inflammation. Thorax 1996;51:1273-1274.
19. McElvaney NG, Doujaiji B, Moan MJ, Burnham MR, Wu MC, Crystal RG: Pharmacokinetics of recombinant secretory leukoprotease inhibitor aerosolized to normals and individuals with cystic fibrosis. Am Rev Respir Dis 1993;148:1056-1060.
20. McElvaney NG, Nakamura H, Birrer P, Hebert CA, Wong WL, Alphonso M, Baker JB, Catalano MA, Crystal RG: Modulation of airway inflammation in cystic fibrosis. In vivo suppression of interleukin-8 levels on the respiratory epithelial surface by aerosolization of recombinant secretory leukoprotease inhibitor. J Clin Invest 1992;90:1296-1301.
21. Vizza CD, Lynch JP, Ochua LL, Richardson G, Trulock EP: Right and left ventricular dysfunction in patients with severe pulmonary disease. Chest 1998;113:576-583.
22. Mack JF, Moss AJ, Harper WW, O'Loughlin BJ: The bronchial arteries in cystic fibrosis. Br J Radiol 1965;38:422-429.
23. Spector M, Stern R: Pneumothorax in cystic fibrosis: A 26-year experience. Ann Thorac Surg 1989;47:204-207.
24. Wilmott RW: Allergy and infection in cystic fibrosis; in Milner AD. Martin RJ (eds): Neonatal and Paediatric Respiratory Medicine. London, Butterworths, 1985, chap 10, pp 190-210.
25. Carr SD, Dinwiddie R: Annual review or continuous assessment. J R Soc Med 1996;89 (suppl 27):3-7.
26. Abman SH, Ogle JW, Butler-Simon N, Rumack CM, Accurso FJ: Role of respiratory syncytial virus in early hospitalizations for respiratory distress of young infants with cystic fibrosis. J Pediatr 1988;113:826-830.
27. Smyth AR, Smyth RL, Tong CY, Hart CA, Heaf DP: Effect of respiratory virus infections including rhinovirus on clinical status in cystic fibrosis. Arch Dis Child 1995;73:117-120.
28. Ramphal R, Guay C, Pier GB: Pseudomonas aeruginosa adhesins for tracheobronchial mucin. Infect Immun 1987;55:600-603.
29. Hata JS, Pick RB Jr: Airway adherence of Pseudomonas aeruginosa: Mucoexopolysaccharide binding to human and bovine airway proteins. J Lab Clin Med 1991;117:410-422.
30. LiPuma JJ: Burkholderia cepacia. Management issues and new insights. Clin Chest Med 1998;19:473-486.
31. Greenberger PA: Immunologic aspects of lung diseases and cystic fibrosis. JAMA 1997;278: 1924-1930.
32. Konstan MW, Berger M: Current understanding of the inflammation process in cystic fibrosis: Onset and etiology. Pediatr Pulmonol 1997;24:137-142.